1abtik pursues a strategy with an as early as possible, massive but short-acting inhibition of several critical pathways to attenuate the devastating hyper-inflammatory phase of these medical conditions. This approach enables the treatment of severe inflammations and allows the immune system to quickly return to normal, as required.
Such multi-target inhibition by highly potent, innovative compounds is a new, potentially game-changing approach.
A cookie is a small text file that a website saves on your computer or mobile device when you visit the site.
We use proprietary and third-party cookies to improve your experience and our services and analyze the use of our website.
By clicking "OK" or navigating this site, you accept the placement and use of these cookies for these purposes.
To learn more about our cookies, please visit our Cookies Policy